Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
miR-21-5p promotes NASH-related hepatocarcinogenesis.
Rodrigues PM, Afonso MB, Simão AL, Islam T, Gaspar MM, O'Rourke CJ, Lewinska M, Andersen JB, Arretxe E, Alonso C, Santos-Laso Á, Izquierdo-Sanchez L, Jimenez-Agüero R, Eizaguirre E, Bujanda L, Pareja MJ, Prip-Buus C, Banales JM, Rodrigues CMP, Castro RE. Rodrigues PM, et al. Among authors: santos laso a. Liver Int. 2023 Oct;43(10):2256-2274. doi: 10.1111/liv.15682. Epub 2023 Aug 3. Liver Int. 2023. PMID: 37534739
Proteostasis disturbances and endoplasmic reticulum stress contribute to polycystic liver disease: New therapeutic targets.
Santos-Laso A, Izquierdo-Sanchez L, Rodrigues PM, Huang BQ, Azkargorta M, Lapitz A, Munoz-Garrido P, Arbelaiz A, Caballero-Camino FJ, Fernández-Barrena MG, Jimenez-Agüero R, Argemi J, Aragon T, Elortza F, Marzioni M, Drenth JPH, LaRusso NF, Bujanda L, Perugorria MJ, Banales JM. Santos-Laso A, et al. Liver Int. 2020 Jul;40(7):1670-1685. doi: 10.1111/liv.14485. Epub 2020 May 6. Liver Int. 2020. PMID: 32378324 Free PMC article.
RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver disease.
Afonso MB, Rodrigues PM, Mateus-Pinheiro M, Simão AL, Gaspar MM, Majdi A, Arretxe E, Alonso C, Santos-Laso A, Jimenez-Agüero R, Eizaguirre E, Bujanda L, Pareja MJ, Banales JM, Ratziu V, Gautheron J, Castro RE, Rodrigues CMP. Afonso MB, et al. Gut. 2021 Dec;70(12):2359-2372. doi: 10.1136/gutjnl-2020-321767. Epub 2020 Dec 24. Gut. 2021. PMID: 33361348 Free PMC article.
Adiponectin, Leptin, and IGF-1 Are Useful Diagnostic and Stratification Biomarkers of NAFLD.
Marques V, Afonso MB, Bierig N, Duarte-Ramos F, Santos-Laso Á, Jimenez-Agüero R, Eizaguirre E, Bujanda L, Pareja MJ, Luís R, Costa A, Machado MV, Alonso C, Arretxe E, Alustiza JM, Krawczyk M, Lammert F, Tiniakos DG, Flehmig B, Cortez-Pinto H, Banales JM, Castro RE, Normann A, Rodrigues CMP. Marques V, et al. Front Med (Lausanne). 2021 Jun 23;8:683250. doi: 10.3389/fmed.2021.683250. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34249975 Free PMC article.
The altered serum lipidome and its diagnostic potential for Non-Alcoholic Fatty Liver (NAFL)-associated hepatocellular carcinoma.
Lewinska M, Santos-Laso A, Arretxe E, Alonso C, Zhuravleva E, Jimenez-Agüero R, Eizaguirre E, Pareja MJ, Romero-Gómez M, Arrese M, Suppli MP, Knop FK, Oversoe SK, Villadsen GE, Decaens T, Carrilho FJ, de Oliveira CP, Sangro B, Macias RIR, Banales JM, Andersen JB. Lewinska M, et al. EBioMedicine. 2021 Nov;73:103661. doi: 10.1016/j.ebiom.2021.103661. Epub 2021 Oct 29. EBioMedicine. 2021. PMID: 34740106 Free PMC article.
Immune Checkpoint Inhibitors: The Emerging Cornerstone in Cholangiocarcinoma Therapy?
Gutiérrez-Larrañaga M, González-López E, Roa-Bautista A, Rodrigues PM, Díaz-González Á, Banales JM, López-Hoyos M, Santos-Laso A, Crespo J. Gutiérrez-Larrañaga M, et al. Among authors: santos laso a. Liver Cancer. 2021 Sep 21;10(6):545-560. doi: 10.1159/000518104. eCollection 2021 Nov. Liver Cancer. 2021. PMID: 34950178 Free PMC article. Review.
New Advances in Polycystic Liver Diseases.
Santos-Laso A, Izquierdo-Sánchez L, Lee-Law PY, Perugorria MJ, Marzioni M, Marin JJ, Bujanda L, Banales JM. Santos-Laso A, et al. Semin Liver Dis. 2017 Feb;37(1):45-55. doi: 10.1055/s-0036-1597817. Epub 2017 Feb 15. Semin Liver Dis. 2017. PMID: 28201848 Review.
Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Cholangitis.
Banales JM, Iñarrairaegui M, Arbelaiz A, Milkiewicz P, Muntané J, Muñoz-Bellvis L, La Casta A, Gonzalez LM, Arretxe E, Alonso C, Martínez-Arranz I, Lapitz A, Santos-Laso A, Avila MA, Martínez-Chantar ML, Bujanda L, Marin JJG, Sangro B, Macias RIR. Banales JM, et al. Hepatology. 2019 Aug;70(2):547-562. doi: 10.1002/hep.30319. Epub 2019 Feb 14. Hepatology. 2019. PMID: 30325540 Free PMC article.
Patients with Cholangiocarcinoma Present Specific RNA Profiles in Serum and Urine Extracellular Vesicles Mirroring the Tumor Expression: Novel Liquid Biopsy Biomarkers for Disease Diagnosis.
Lapitz A, Arbelaiz A, O'Rourke CJ, Lavin JL, Casta A, Ibarra C, Jimeno JP, Santos-Laso A, Izquierdo-Sanchez L, Krawczyk M, Perugorria MJ, Jimenez-Aguero R, Sanchez-Campos A, Riaño I, Gónzalez E, Lammert F, Marzioni M, Macias RIR, Marin JJG, Karlsen TH, Bujanda L, Falcón-Pérez JM, Andersen JB, Aransay AM, Rodrigues PM, Banales JM. Lapitz A, et al. Cells. 2020 Mar 14;9(3):721. doi: 10.3390/cells9030721. Cells. 2020. PMID: 32183400 Free PMC article.
35 results